Filing Details
Ovid Therapeutics Inc. (NASDAQ:OVID) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:OVID
Ovid Therapeutics Inc. (OVID) Files Quarterly Report for Q0
Ovid Therapeutics Inc. (NASDAQ:OVID) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
At publication ·
What changed
Ovid Therapeutics Inc. (NASDAQ:OVID) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Ovid Therapeutics Inc. filed its quarterly report (Form 10-Q) with the SEC on August 13, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $2.80 per share with a market capitalization of $117.3 million as of the filing date.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last annual filing.
Market Context
Ovid Therapeutics Inc.'s stock currently trades at $2.80 with a market capitalization of $117.3M.
The 10-Q provides Ovid Therapeutics Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Ovid Therapeutics Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View OVID Stock Page
Frequently Asked Questions
Where can I read OVID's SEC filings?
Browse all filings on our OVID SEC filings page.
What types of SEC filings does Ovid Therapeutics Inc. file?
Public companies like Ovid Therapeutics Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.